A vs. B | B vs. C | |||||
---|---|---|---|---|---|---|
OR | 95% CI | P | OR | 95% CI | P | |
Age (》 65 years) | 2.105 | 0.706~6.280 | 0.182 | 1.75 | 0.571~5.360 | 0.327 |
Gender (male) | 0.727 | 0.280~1.887 | 0.513 | 1 | 0.375~2.664 | 1 |
BMI (》 25 Kg/m2) | 1.203 | 0.431~3.356 | 0.724 | 1.203 | 0.431~3.356 | 0.724 |
Previous abdominal surgical history (yes) | 0.357 | 0.098~1.300 | 0.118 | 2.653 | 0.294–23.922 | 0.385 |
Distance of tumor from anal verge (cm) | ||||||
 2 ≦ | 1 | 1 | ||||
 2 < *< 4 | 0.197 | 0.049~0.790 | 0.022 | 0.064–1.425 | 0.13 | |
 ≧ 4 | 0.46 | 0.159~1.328 | 0.151 | 0.105–0.867 | 0.026 | |
Maximum diameter of mass (cm) | ||||||
 2 ≦ | 1 | 1 | ||||
 2 < * < 4 | 1.591 | 0.395~6.407 | 0.514 | 1.909 | 0.563–6.477 | 0.3 |
 ≧ 4 | 0.625 | 0.181~2.155 | 0.457 | 1.455 | 0.454–4.655 | 0.528 |
ASA classification | 2.57 | 0.812~8.132 | 0.108 | 1.123 | 0.353–3.567 | 0.845 |
Neoadjuvant therapy (yes) | 4.6 | 1.4~15.117 | 0.012 | 1.6 | 0.610–4.139 | 0.339 |
CE (》 5 ng/ml) | 1.395 | 0.440~4.424 | 0.572 | 1.395 | 0.440–4.424 | 0.572 |
CA19-9 (》 37 U/ml) | 0.308 | 0.048~1.964 | 0.213 | 0.481 | 0.064–3.614 | 0.477 |
T stage | ||||||
 T0 | 1 | 1 | ||||
 T1 | 1.436 | 0.00~2.176 | 0.999 | 1.974 | 0–2.324 | 0.999 |
 T2 | 1 | 0.260~3.845 | 1 | 2.2 | 0.54–8.957 | 0.27 |
 T3 | 2.424 | 0.747~7.862 | 0.14 | 3.333 | 1.088–10.211 | 0.035 |
N stage | ||||||
 N0 | 1 | 1 | ||||
 N1 | 1.119 | 0.096~13.032 | 0.928 | 0 | 0–2.221 | 0.999 |
 N2 | 0.615 | 0.034~7.452 | 0.615 | 0 | 0–2.324 | 0.999 |
TNM comprehensive staging | ||||||
 0 | 1 | 1 | ||||
 I | 1.615 | 0~2.157 | 0.999 | 1.615 | 0–2.221 | 0.999 |
 II | 2.059 | 0.577~7.341 | 0.266 | 2.5 | 0.688–9.084 | 0.164 |
 III | 1.75 | 0.329~9.298 | 0.511 | 1 | 0.214–4.674 | 1 |